The Form 144 filing by CEO Grant Pickering is a routine advance notice of intent to sell a modest number of shares relative to the company's $8.1B market cap. The proposed sale (~$1.30M) is consistent with normal portfolio diversification and does not signal distress. Monitor for actual Form 4 filings to confirm execution, but no immediate trading action is warranted.
Price Chart
Executive Summary
CEO Grant Pickering filed a Form 144 notice of intent to sell 24,237 shares of Vaxcyte (PCVX) with an approximate market value of $1.30M, alongside 2,000 additional shares from family trusts. The filing signals insider selling intent but is a routine diversification move by the CEO, not a distress signal, given the company's $8.1B market cap and strong institutional backing.
Key Facts
- CEO Grant Pickering filed Form 144 to sell 24,237 shares of Vaxcyte common stock, valued at approximately $1.30M based on the filing date.
- An additional 2,000 shares are being sold via family trusts (Claire Pickering 2020 Delaware Trust and Benjamin Pickering 2020 Delaware Trust), each valued at ~$52,500.
- The shares to be sold were acquired through RSU vesting (2023-2025), founder shares (2013), and prior RSU vesting (2024).
- The filing is an advance notice of intent to sell, not a completed transaction — the sale may not occur.
- Recent insider activity (30d) shows 9 sells totaling $1.3M, consistent with routine insider selling patterns.
Financial Impact
CEO proposes to sell ~24,237 shares worth ~$1.30M, representing a small fraction of the $8.1B market cap and likely a small portion of the insider's total holdings.
Risk Factors
- Insider selling could be misinterpreted by the market as a lack of confidence, though the amount is small relative to market cap.
- The sale is not yet executed — the insider may choose not to sell, making the filing a non-event.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001969223-26-000725 |
| Document: 0001969223-26-000725-index.html | 0001969223-26-000725 |
| Document: 0001969223-26-000725.txt | 0001969223-26-000725 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | Insider Cluster | $55.92 $61.58 | ▲ +10.12% | ▲ +10.72% | $56.69 (+1.38%) |
Jul 6, 2026 12w ago | Insider Cluster | $60.67 $53.53 | ▼ −11.77% | ▼ −13.10% | $56.69 (−6.56%) |
Jul 6, 2026 12w ago | Insider Cluster | $60.67 $53.53 | ▼ −11.77% | ▼ −13.10% | $56.69 (−6.56%) |
Jun 26, 2026 13w ago | 144 | $57.72 $54.66 | ▼ −5.30% | ▼ −5.02% | $56.69 (−1.78%) |
Jun 23, 2026 14w ago | 8-K | $53.87 $56.00 | ▲ +3.95% | ▲ +2.02% | $56.69 (+5.23%) |
Jun 19, 2026 15w ago | Insider Cluster | $52.11 $56.20 | ▲ +7.85% | ▲ +8.00% | $56.69 (+8.79%) |
Jun 2, 2026 17w ago | Press Release | $46.93 $58.39 | ▲ +24.42% | ▲ +25.42% | $56.69 (+20.80%) |
May 6, 2026 21w ago | 8-K | $51.48 $46.93 | ▲ +8.84% | ▲ +11.97% | $56.69 (−10.12%) |
Apr 23, 2026 23w ago | DEFA14A | $59.49 $47.39 | ▼ −20.34% | ▼ −24.37% | $56.69 (−4.71%) |
Apr 1, 2026 26w ago | Insider Cluster | $58.50 $57.32 | ▼ −2.02% | ▼ −11.74% | $56.69 (−3.09%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access